chr21-42219222-C-CCCGCCG
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_016818.3(ABCG1):c.-14_-9dup variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0403 in 1,468,542 control chromosomes in the GnomAD database, including 856 homozygotes. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.038 ( 154 hom., cov: 26)
Exomes 𝑓: 0.041 ( 702 hom. )
Consequence
ABCG1
NM_016818.3 5_prime_UTR
NM_016818.3 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0270
Genes affected
ABCG1 (HGNC:73): (ATP binding cassette subfamily G member 1) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. It is involved in macrophage cholesterol and phospholipids transport, and may regulate cellular lipid homeostasis in other cell types. Six alternative splice variants have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 21-42219222-C-CCCGCCG is Benign according to our data. Variant chr21-42219222-C-CCCGCCG is described in ClinVar as [Benign]. Clinvar id is 3037187.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0376 (5652/150262) while in subpopulation NFE AF= 0.0504 (3396/67326). AF 95% confidence interval is 0.049. There are 154 homozygotes in gnomad4. There are 2622 alleles in male gnomad4 subpopulation. Median coverage is 26. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 154 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ABCG1 | NM_016818.3 | c.-14_-9dup | 5_prime_UTR_variant | 1/15 | ENST00000398449.8 | ||
LOC105372814 | XR_937748.4 | n.121+927_121+928insCGGCGG | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ABCG1 | ENST00000398449.8 | c.-14_-9dup | 5_prime_UTR_variant | 1/15 | 1 | NM_016818.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0376 AC: 5649AN: 150158Hom.: 153 Cov.: 26
GnomAD3 genomes
AF:
AC:
5649
AN:
150158
Hom.:
Cov.:
26
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0209 AC: 1595AN: 76150Hom.: 14 AF XY: 0.0224 AC XY: 957AN XY: 42682
GnomAD3 exomes
AF:
AC:
1595
AN:
76150
Hom.:
AF XY:
AC XY:
957
AN XY:
42682
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0406 AC: 53585AN: 1318280Hom.: 702 Cov.: 20 AF XY: 0.0406 AC XY: 26450AN XY: 651180
GnomAD4 exome
AF:
AC:
53585
AN:
1318280
Hom.:
Cov.:
20
AF XY:
AC XY:
26450
AN XY:
651180
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0376 AC: 5652AN: 150262Hom.: 154 Cov.: 26 AF XY: 0.0357 AC XY: 2622AN XY: 73394
GnomAD4 genome
AF:
AC:
5652
AN:
150262
Hom.:
Cov.:
26
AF XY:
AC XY:
2622
AN XY:
73394
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
ABCG1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 21, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at